ST Premium

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market.Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!

PLRZ Company Profile and Key Details

NASDAQ : PLRZ

Polyrizon Ltd.

$0.34

-0.005-1.45%

Open: 10:58 AM

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

PLRZ Stock Price Chart

Stock Price Today

Polyrizon Ltd. (PLRZ) stock declined over -1.45%, trading at $0.34 on NASDAQ, down from the previous close of $0.35. The stock opened at $0.33, fluctuating between $0.32 and $0.38 in the recent session.

Stock Snapshot

0.346

Prev. Close

0.33

Open

1.5M

Market Cap

4.39M

Number of Shares

0.32

Day Low

0.38

Day High

-0.68

P/E Ratio

97.06%

Free Float in %

-0.5

EPS (TTM)

N/A

Book Value

N/A

Cash Flow per Share

50.99K

Volume

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Apr 04, 2025	0.35	0.40	0.32	0.35	258.2K
Apr 03, 2025	0.38	0.41	0.35	0.36	442K
Apr 02, 2025	0.35	0.41	0.34	0.39	377.92K
Apr 01, 2025	0.36	0.38	0.33	0.36	236.44K
Mar 31, 2025	0.49	0.62	0.28	0.37	1.72M
Mar 28, 2025	0.51	0.52	0.45	0.48	223.55K
Mar 27, 2025	0.46	0.53	0.46	0.50	377.1K
Mar 26, 2025	0.51	0.54	0.45	0.47	1.23M
Mar 25, 2025	0.65	0.68	0.51	0.54	3.35M
Mar 24, 2025	0.53	0.86	0.47	0.75	1.73M
Mar 21, 2025	0.58	0.60	0.52	0.56	97.08K
Mar 20, 2025	0.54	0.58	0.51	0.56	195.21K
Mar 19, 2025	0.60	0.60	0.56	0.57	61.8K
Mar 18, 2025	0.64	0.64	0.55	0.59	65.38K
Mar 17, 2025	0.54	0.64	0.54	0.64	309.7K
Mar 14, 2025	0.59	0.61	0.54	0.56	2.82M
Mar 13, 2025	0.72	0.72	0.67	0.68	27.38K
Mar 12, 2025	0.75	0.80	0.70	0.70	32.47K
Mar 11, 2025	0.78	0.82	0.74	0.75	64.05K
Mar 10, 2025	0.81	0.90	0.76	0.80	64.02K

Contact Details

Ra'anana, 4366507

Israel

Website: https://www.polyrizon-biotech.comContact: 972 937 40120

About Company

Polyrizon Ltd., a biotech company, engages in the development of medical device hydrogels in the form of nasal sprays in Israel. The company's nasal sprays provide a barrier against viruses and allergens from contacting the nasal epithelial tissue. It develops PL-14, a nasal allergies blocker; PL-15 for COVID-19; and PL-16 for influenza. The company was incorporated in 2005 is headquartered in Ra'anana, Israel.

Frequently Asked Questions

What is the current Polyrizon Ltd. (PLRZ) stock price?

Polyrizon Ltd. (NASDAQ: PLRZ) stock price is $0.34 in the last trading session. During the trading session, PLRZ stock reached the peak price of $0.38 while $0.32 was the lowest point it dropped to. The percentage change in PLRZ stock occurred in the recent session was -1.45% while the dollar amount for the price change in PLRZ stock was -$0.01.

PLRZ's industry and sector of operation?

The NASDAQ listed PLRZ is part of Biotechnology industry that operates in the broader Healthcare sector. Polyrizon Ltd. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of PLRZ?

No Data

How PLRZ did perform over past 52-week?

PLRZ's closing price is 23.13% higher than its 52-week low of $0.28 where as its distance from 52-week high of $4.80 is -92.79%.

How many employees does PLRZ have?

Number of PLRZ employees currently stands at 2.

Link for PLRZ official website?

Official Website of PLRZ is: https://www.polyrizon-biotech.com

How do I contact PLRZ?

PLRZ could be contacted at phone 972 937 40120 and can also be accessed through its website. PLRZ operates from 5 Ha-Tidhar Street, Ra'anana, 4366507, Israel.

How many shares of PLRZ are traded daily?

PLRZ stock volume for the day was 50.99K shares. The average number of PLRZ shares traded daily for last 3 months was 337.6K.

What is the market cap of PLRZ currently?

The market value of PLRZ currently stands at $1.50M with its latest stock price at $0.34 and 4.39M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

About

Home About Meet The Team Contact Us Privacy Policy Newsletter

Employees	2
Beta	-15.03
Sales or Revenue	N/A
5Y Sales Change%	N/A
Fiscal Year Ends	N/A
Sector	Healthcare
Industry	Biotechnology